DD vs NGNE · P/E 127, rev $3.50B vs $286.5M cap
Dupont De Nemours Inc (DD) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. NGNE currently screens at market cap $286.5M.
Not investment advice. Open the DD and NGNE stock pages for the full models.
Not investment advice.